INTIMATION FOR BODHIKA SEMINAR - 13/07/2022
DEPARTMENTS OF AGADA TANTRA & RASA SHASTRA AND BHAISHAJYA KALPANA
NAME OF CO-GUIDE: Dr SURAJ K
TIME: 2:00-4:00 PM
VENUE: HYBRID / MICROSOFT TEAMS
ABSTRACT
In
the current scenario drug induced toxicity is a major headache to the health
sector limiting the usefulness of widely used agents. The development of
severe, drug related complications may require premature drug withdrawal or
dose reduction. In some cases, toxicity occurs in majority of treated
individuals because of the nature of the drug (e.g. cytotoxic agents used for
cancer-chemotherapy). Cisplatin (Cis-diamminedichloroplatinum II) is one of the
most widely used and highly effective chemotherapeutic agents. Its treatment
has been linked to various toxic side effects including nephrotoxicity,
myelosuppression, cardiotoxicity etc. Acute kidney injury occurs in 21-31.55%
patients receiving cisplatin-based chemotherapy. Now worldwide, 850 million
people are estimated to have kidney diseases from various causes and are the 10th
fastest growing cause of death. In this study we are aiming to provide relief
to patients on cisplatin medication. For this purpose, Sugandhadi agada,
a formulation mentioned under mandali visha prakarana of Ashtanga
Hridaya, Uttarasthana Sarpavisha Prathishedha is selected. Mandali Visha
can be correlated to Viper envenomation by its signs and symptoms, the mode of
death etc. In Viper envenomation, the mainly affected system is circulatory
system and death may be due to acute renal failure. Therefore, the treatment
will definitely target the circulatory and renal system. Hence, this work aims
to study the nephroprotective effect of the formulation mentioned under mandali
visha prakarana to tackle the aftereffects of xenobiotics causing
nephrotoxicity. Physico-chemical analysis of the formulation was conducted at Department
of Chemistry, Siddha Regional Research Institute, Poojappura Thiruvananthapuram
and Sophisticated Test and Instrumentation Centre (STIC), CUSAT. The
experimental study was conducted at Amala Cancer Research Center, Thrissur. Male
wistar rats weighing 150-200g purchased from authentic breeding centers and
were divided into 6 groups containing 6 animals each. The groups selected for
the study are; normal, vehicle control, Cisplatin (7mg/ kg body wt.), Sugandhadi
agada at high, therapeutic and low doses along with cisplatin. All the
groups received their respective drugs for 14 days, except Cisplatin which was
given on 10th day. Changes in the animals observed and animal sacrificed at the
end of 14th day. Changes in hematological parameters- serum urea, serum
creatinine, serum uric acid, serum alkaline phosphatase, serum bilirubin were
assessed after collecting blood through heart puncture. Enzymatic activities
along with histopathological changes in kidney were also evaluated.
Results were statistically analyzed by one way ANOVA, followed by Tukey’s multiple comparison tests as
post-hoc test. The overall
result suggests that the Sugandhadi agada has no significant nephroprotective
effects against cisplatin induced nephrotoxicity in this study.
NAME OF CO-GUIDE: Dr C V MEENA
TIME: 2:00-4:00 PM
VENUE: HYBRID / MICROSOFT TEAMS
ABSTRACT
No comments:
Post a Comment